Correlation Between Kiora Pharmaceuticals and Verona Pharma
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Verona Pharma PLC, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Verona Pharma.
Diversification Opportunities for Kiora Pharmaceuticals and Verona Pharma
-0.28 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Kiora and Verona is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Verona Pharma go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Verona Pharma
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to under-perform the Verona Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Kiora Pharmaceuticals is 1.16 times less risky than Verona Pharma. The stock trades about -0.26 of its potential returns per unit of risk. The Verona Pharma PLC is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 3,311 in Verona Pharma PLC on August 27, 2024 and sell it today you would earn a total of 570.00 from holding Verona Pharma PLC or generate 17.22% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Verona Pharma PLC
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Verona Pharma PLC |
Kiora Pharmaceuticals and Verona Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Verona Pharma
The main advantage of trading using opposite Kiora Pharmaceuticals and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| Verona Pharma vs. Ventyx Biosciences | Verona Pharma vs. Ideaya Biosciences | Verona Pharma vs. Protagonist Therapeutics | Verona Pharma vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |